Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal

Abstract : Breast cancer remains a research priority due to its invasive phenotype. Although the role of ion channels in cancer is now well established, the role of inositol (1,4,5)-trisphosphate (IP3) receptors (IP(3)Rs) remains enigmatic. If the three IP3Rs subtypes expression have been identified in various cancers, little is known about their physiological role. Here, we investigated the involvement of IP3R type 3 (IP3R3) in the migration processes of three human breast cancer cell lines showing different migration velocities: the low-migrating MCF-7 and the highly migrating and invasive MDA-MB-231 and MDA-MB-435S cell lines. We show that a higher IP3R3 expression level, but not IP3R1 nor IP3R2, is correlated to a stronger cell line migration capacity and a sustained calcium signal. Interestingly, silencing of IP3R3 highlights an oscillating calcium signaling profile and leads to a significant decrease of cell migration capacities of the three breast cancer cell lines. Conversely, stable overexpression of IP3R3 in MCF-7 cells significantly increases their migration capacities. This effect is completely reversed by IP3R3 silencing. In conclusion, we demonstrate that IP3R3 expression level increases the migration capacity of human breast cancer cells by changing the calcium signature.
Type de document :
Article dans une revue
Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03607840
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : lundi 14 mars 2022 - 11:49:20
Dernière modification le : mardi 15 mars 2022 - 03:00:21

Lien texte intégral

Identifiants

Collections

Citation

Abdallah Mound, Alexia Vautrin-Glabik, Arthur Foulon, Beatrice Botia, Frederic Hague, et al.. Downregulation of type 3 inositol (1,4,5)-trisphosphate receptor decreases breast cancer cell migration through an oscillatory Ca2+ signal. Oncotarget, 2017, 8 (42), pp.72324-72341. ⟨10.18632/oncotarget.20327⟩. ⟨hal-03607840⟩

Partager

Métriques

Consultations de la notice

2